The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 03, 2017
Filed:
Jun. 08, 2015
Applicant:
Poly-med, Inc., Anderson, SC (US);
Inventors:
Shalaby W. Shalaby, Anderson, SC (US);
Georgios T. Hilas, Anderson, SC (US);
Kenneth David Gray, Clemson, SC (US);
Assignee:
Poly-Med, Inc., Anderson, SC (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 25/34 (2006.01); A61K 31/7036 (2006.01); B65D 65/38 (2006.01); A61K 9/00 (2006.01); A61K 31/12 (2006.01); A61K 31/192 (2006.01); A61K 31/337 (2006.01); A61K 31/4025 (2006.01); A61K 31/4164 (2006.01); A61K 31/4174 (2006.01); A61K 31/427 (2006.01); A61K 31/436 (2006.01); A61K 31/497 (2006.01); A61K 31/506 (2006.01); A61K 31/65 (2006.01); A61K 47/34 (2006.01); A61M 25/04 (2006.01); A61M 31/00 (2006.01); A61K 31/4196 (2006.01); A61K 31/496 (2006.01); A61K 31/505 (2006.01); A61M 25/10 (2013.01); B65B 3/04 (2006.01); B65B 51/10 (2006.01); B65B 55/04 (2006.01); B65B 55/14 (2006.01); A61M 25/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7036 (2013.01); A01N 25/34 (2013.01); A61K 9/0034 (2013.01); A61K 9/0053 (2013.01); A61K 31/12 (2013.01); A61K 31/192 (2013.01); A61K 31/337 (2013.01); A61K 31/4025 (2013.01); A61K 31/4164 (2013.01); A61K 31/4174 (2013.01); A61K 31/4196 (2013.01); A61K 31/427 (2013.01); A61K 31/436 (2013.01); A61K 31/496 (2013.01); A61K 31/497 (2013.01); A61K 31/505 (2013.01); A61K 31/506 (2013.01); A61K 31/65 (2013.01); A61K 47/34 (2013.01); A61M 25/002 (2013.01); A61M 25/04 (2013.01); A61M 25/10 (2013.01); A61M 31/00 (2013.01); A61M 31/007 (2013.01); B65B 3/04 (2013.01); B65B 51/10 (2013.01); B65B 55/04 (2013.01); B65B 55/14 (2013.01); B65D 65/38 (2013.01); A61M 2025/0024 (2013.01); A61M 2025/105 (2013.01);
Abstract
Bioactive, hydroforming luminal liner compositions are formed of high molecular weight crystalline, absorbable copolyesters dissolved in a liquid derivative of a polyether glycol that undergoes transformation into a tissue-adhering, resilient interior cover or liner for the controlled release of its bioactive payload at clinically compromised conduits in humans as in the case of bacteria- and yeast-infected vaginal canals, esophagi, and arteries following angioplasty.